Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|March 28, 2009
Adjuvant chemotherapy for colon cancer in the elderly: moving from evidence to practiceSteven AdesInternational Journal of Clinical Oncology|September 16, 2016
Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory studyMasanori Mori, Yongli Ji, Santosh Kumar, et al.Gastrointestinal Cancer Research : GCR|May 7, 2014
Absence of anaplastic lymphoma kinase translocations in signet ring cell carcinomas of the upper gastrointestinal tractJill Miller, Zhihua Peng, Rebecca Wilcox, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2012
In-advance end-of-life discussions and the quality of inpatient end-of-life care: a pilot study in bereaved primary caregivers of advanced cancer patientsMasanori Mori, Donna Ellison, Takamaru Ashikaga, et al.Cancer Medicine|February 7, 2022
Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER-Medicare analysisSteven Ades, Bhargavi Pulluri, Chris E Holmes, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 30, 2016
Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT)Steven Ades, M Halyard, K Wilson, et al.Clinical Colorectal Cancer|January 15, 2022
The Potential for Overtreatment With Total Neoadjuvant Therapy (TNT): Consider One Local Therapy InsteadChristopher J Anker, Nataniel H Lester-Coll, Dmitriy Akselrod, et al.International Journal of Oncology|February 9, 2006
Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitorsSteven Ades, Lori F Maxfield, Christopher J Gould, et al.The Oncologist|October 5, 2020
Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from ImmunotherapyMansour Gergi, Kara K Landry, Steven Ades, et al.Journal of Thrombosis and Haemostasis : JTH|August 20, 2019
Risk factors for cancer-associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) studyDaniel R Douce, Chris E Holmes, Mary Cushman, et al.Pageof 3